Hoer Michael A.

Director

Medifast, Inc.

US, Baltimore [HQ]

CIK 1743755

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

8,325,709

Price per Share :

$15.52

Equivalence :

$129,215,003.68

Transaction History

P

Form 4

8,325,709 Shares After Transaction

Value : $744,484,898.78

$3,366,126.48

Transaction Date : 08/08/23
- Footnotes
- Form 4
Footnotes:
#1 Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.
A

Form 4

14,971,473 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 06/20/24
- Footnotes
- Form 4
Footnotes:
#1 6,596 restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These awards are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025.
P

Form 4

5,170,065 Shares After Transaction

Value : $452,380,687.50

$1,117,550.00

Transaction Date : 05/09/23
- Footnotes
- Form 4
Footnotes:
#1 Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.
P

Form 4

8,375,473 Shares After Transaction

Value : $576,986,334.97

$3,428,241.96

Transaction Date : 11/07/23
- Footnotes
- Form 4
Footnotes:
#1 Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.
A

Form 4

8,288,065 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 06/15/23
- Footnotes
- Form 4
Footnotes:
#1 Represents the right to receive 3,118 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024.